References

Pan-Canadian study of mammography screening and mortality from breast cancer

10.1093/jnci/dju261 · 2014 · External reference

The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies

10.1258/jms.2012.012078 · 2012 · External reference

Mammographic screening and breast cancer mortality: a case-control study and meta-analysis

10.1158/1055-9965.epi-12-0468 · 2012 · External reference

Recent trends in breast cancer mortality rates for U.S. women by age and race/ethnicity

10.1093/jbi/wbaf007 · 2025 · External reference

The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening

10.1002/cncr.31840 · 2019 · External reference

Mammography screening reduces rates of advanced and fatal cancers: results in 549,091 women

10.1002/cncr.32859 · 2020 · External reference

Outcomes of breast cancer screening strategies based on Cancer Intervention and Surveillance Modeling Network estimates

10.1148/radiol.232658 · 2024 · External reference

Unresolved reference

External reference

The WISDOM study: breaking the deadlock in the breast cancer screening debate

10.1038/s41523-017-0035-5 · 2017 · External reference

Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study

10.1186/s12885-025-13848-z · 2025 · External reference

Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR

10.1016/j.jacr.2023.04.002 · 2023 · External reference

Risk-based vs annual breast cancer screening: the WISDOM randomized clinical trial

10.1001/jama.2025.24784 · 2026 · External reference

The WISDOM trial is based on faulty reasoning and has major design and execution problems

10.1007/s10549-020-06020-7 · 2021 · External reference

ACR withdraws from WISDOM breast cancer screening trial

2019 · External reference

Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients

10.1136/bmj.h4901 · 2015 · External reference

135P Real-time genotyping-based breast cancer risk assessment in MyPeBS, an international randomized trial in the general population comparing risk-stratified to standard breast cancer screening (BCS)

10.1016/j.annonc.2022.03.152 · 2022 · External reference

Tailored breast screening trial (TBST)

2013 · External reference

Personalized screening for breast cancer: rationale, present practices, and future directions

10.1245/s10434-020-09426-1 · 2021 · External reference

Unlocking the potential of risk-based screening for breast cancer form detection to prevention

10.1001/jama.2025.24817 · 2026 · External reference

Preventive care: how mammography utilization changes as women age

10.1016/j.jacr.2019.09.008 · 2020 · External reference

Breast screening utilization and cost sharing among employed insured women after the affordable care act

10.1016/j.jacr.2019.01.028 · 2019 · External reference

Screening mammography for free: impact of eliminating cost sharing on cancer screening rates

10.1111/1475-6773.12486 · 2017 · External reference

Athena Breast Health Network Investigators. Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial

10.1093/jnci/djw290 · 2017 · External reference

Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs’ attitudes

10.3399/bjgp17x689377 · 2017 · External reference

Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update

10.1200/jco.19.01472 · 2019 · External reference

Age distributions of breast cancer diagnosis and mortality by race and ethnicity in United States women

10.1002/cncr.33846 · 2021 · External reference

A deep learning mammography-based model for improved breast cancer risk prediction

10.1148/radiol.2019182716 · 2019 · External reference

Unresolved reference

2005 · External reference